All Rights Reserved. Forward ® 2018
EBD Group Inc., 3150 Pio Pico Drive, Suite 201, 92008 Carlsbad, CA

DOWNLOAD THE REPORT NOW

Submit

Alongside venture capital and public market investment, biopharmaceutical company alliances remain key sources of capital for advancing drug discovery and development efforts across the industry. 

In this report, review the last 18 months of biopharma dealmaking:   

  • 243 alliances with a disclosed potential deal value of >$50 million   

  • 52 biopharma company acquisitions with disclosed upfront payments that were worth nearly $184 billion in guaranteed payments    

Get ahead of your future dealmaking at BioPharm America with this report. 


Download the report to read more! 


GET THE FACTS BEFORE THE DEAL  

THE ULTIMATE BIOPHARMA DEALMAKERS REPORT FOR ALLIANCES AND M&As

WHERE LIFE SCIENCE LEADERS PARTNER AND ACCELERATE GROWTH

LEARN MORE >>

Build strategic partnerships and grow your knowledge with the brightest minds in biotech, pharma and finance.

Fix the following errors:
Hide